scispace - formally typeset
R

Ruth Newbury-Ecob

Researcher at University Hospitals Bristol NHS Foundation Trust

Publications -  58
Citations -  5335

Ruth Newbury-Ecob is an academic researcher from University Hospitals Bristol NHS Foundation Trust. The author has contributed to research in topics: Exome sequencing & Exome. The author has an hindex of 27, co-authored 56 publications receiving 4193 citations. Previous affiliations of Ruth Newbury-Ecob include St. Michael's GAA, Sligo & St. Michael's Hospital.

Papers
More filters
Journal ArticleDOI

Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders

Tarjinder Singh, +61 more
- 01 Apr 2016 - 
TL;DR: In this article, the authors found a genome-wide significant association between rare loss-of-function (LoF) variants in SETD1A and risk for schizophrenia (P = 3.3 × 10−9).
Journal ArticleDOI

Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study

TL;DR: WES improved the identification of genetic disorders in fetuses with structural abnormalities; however, before clinical implementation, careful consideration should be given to case selection to maximise clinical usefulness.
Journal ArticleDOI

Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing

Alejandro Sifrim, +81 more
- 01 Aug 2016 - 
TL;DR: Exome sequenced 1,891 probands and identified three genome-wide significant S-CHD disorders caused by DNMs in CHD4, CDK13 and PRKD1, finding evidence for distinct genetic architectures underlying the low sibling recurrence risk in S- CHD and NS-CHd.
Journal ArticleDOI

Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome.

TL;DR: It is hypothesized that TAR syndrome is associated with a deletion on chromosome 1q21.1 but that the phenotype develops only in the presence of an additional as-yet-unknown modifier (mTAR), and the absence of this deletion in a cohort of control individuals argues for a specific role played by the microdeletion in the pathogenesis of TAR Syndrome.